IP Library Granted Patent US 8,212,007
Granted Patent B2
US 8,212,007 · App. 13/085,093 · Granted Jul 3, 2012

Expression and purification of HIP/PAP and uses therefor

Assignee: The Board of Regents of the University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,212,007
App. No.
13/085,093
Granted
Jul 3, 2012
Kind
B2
Abstract

The present invention relates to methods of compositions comprising RegIII and HIP/PAP proteins, including the use of such proteins as diagnostic and therapeutic targets.

Claims (5)

1. An antimicrobial composition comprising a pharmaceutical carrier and:

(i) a protein comprising the amino acid sequence of SEQ ID NO:21, but said protein lacks residues 1-37 of SEQ ID NO: 11, or

(ii) an isolated nucleic acid molecule encoding the protein of (i).

2. The antimicrobial composition of claim 1 , wherein the composition is bactericidal.

3. The antimicrobial composition of claim 1 , wherein the protein consists of the amino acid sequence of SEQ ID NO:21.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 31, 2011
From: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026358/0444 →
Continuity (4)
Division 12026010 · Feb 5, 2008
Provisional Application 60889424 · Feb 12, 2007
Provisional Application 60970462 · Sep 6, 2007
Related Publication 20110229435A1 · Sep 22, 2011